CorporateGovernance
Disqualification Deferred: How M.K. Rajagopalan Dilutes Section 164(2)(b)
by Sharada A. Kalale* and Shreya Sahu**
SEBI clears Piramal Pharma Limited of alleged violations of LODR Regulations over non-disclosure of material events
The brief closure of Digwal unit or imposition of monetary penalty, in terms of the NGT Order, did not require any disclosure in terms of regulation 30(4)(i) of the LODR Regulations.